Not Tagged
Not Tagged
['leusm']
#asco22 #leusm odenike: idh mutations may convey adverse risk with intensive chemo (controversial) but aza/ven performs well in this setting. and, of course, aza/idhi also frontline options. unclear whether better vs aza/ven. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)